A Registry for Patients With Systemic Mastocytosis in China

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-01

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Registry for Patients With Systemic Mastocytosis in China is a voluntary, observational database that will capture demographic, socioeconomic, and disease information with systemic mastocytosis. No experimental intervention is involved.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mast Cell Connect: A Registry for Patients With Mastocytosis

NCT02620254

Mastocytosis

COMPLETED

Mastocytosis Registry (of Zurich)

NCT06466889

Mastocytosis Hypertryptasemia

RECRUITING

Study of Factors Regulating Mast Cell Proliferation

NCT00044122

Mastocytosis Monoclonal Bone Marrow +1 more

RECRUITING

Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis

NCT04318600

Lupus Nephritis Mesenchymal Stem Cells

COMPLETED PHASE1

Characteristics of Mast Cells in Mastocytosis

NCT00001356

Mastocytosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Systemic Mastocytosis (SM) is an extremely rare and heterogeneous spectrum of diseases characterized by the buildup of genetically altered mast cells in bone marrow sections and/or other extracutaneous organ(s). SM has not been given enough attention in China at present, and the epidemiological data in China are not clear. To understand the epidemiological characteristics and distribution patterns of SM patients in China. To establish a China-wide database platform for registering SM patients and to develop uniform registration standards and processes; to register SM patients who meet the enrollment criteria nationwide through a multicenter collaborative approach and to collect information on their baseline data, clinical manifestations, laboratory tests, treatment regimens, and follow-up results; to perform quality control and data cleansing on the information collected in the registration database, as well as to perform descriptive and inferential statistical analyses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Systemic Mastocytoses

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Any patient with a diagnosis of systemic mastocytosis according to World Health Organization (WHO) classification, including subtypes of SM, who is willing and able to provide written online informed consent.